Cardtronics Rises On Unusually High Volume (CATM)

NEW YORK ( TheStreet) -- Cardtronics (Nasdaq: CATM) is trading at unusually high volume Friday with 1.4 million shares changing hands. It is currently at 4.2 times its average daily volume and trading up 56 cents (+2.2%) at $26.05 as of 11:50 a.m. ET.

Cardtronics has a market cap of $1.21 billion and is part of the services sector and diversified services industry. Shares are down 5.8% year to date as of the close of trading on Thursday.

Cardtronics, Inc., together with its subsidiaries, provides automated consumer financial services through its network of automated teller machines (ATMs) and multi-function financial services kiosks. The company has a P/E ratio of 16.4, below the average diversified services industry P/E ratio of 17.5 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Cardtronics as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated. You can view the full Cardtronics Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVUP to 95370 or select from multiple alert options.

null

More from Markets

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus